Cargando…

An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma

BACKGROUND: Sarcomas are rare, often fatal malignancies of connective tissues that can occur in genetic predisposition syndromes or result from carcinogen exposure. Hodgkin's lymphoma (HL) is not known to contribute to any recognised familial cancer syndrome comprising sarcomas, but is known to...

Descripción completa

Detalles Bibliográficos
Autores principales: Downing, Megan E, Dite, Gillian S, Ballinger, Mandy L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351710/
https://www.ncbi.nlm.nih.gov/pubmed/22588051
http://dx.doi.org/10.1186/2045-3329-2-1
_version_ 1782232792446271488
author Downing, Megan E
Dite, Gillian S
Ballinger, Mandy L
author_facet Downing, Megan E
Dite, Gillian S
Ballinger, Mandy L
author_sort Downing, Megan E
collection PubMed
description BACKGROUND: Sarcomas are rare, often fatal malignancies of connective tissues that can occur in genetic predisposition syndromes or result from carcinogen exposure. Hodgkin's lymphoma (HL) is not known to contribute to any recognised familial cancer syndrome comprising sarcomas, but is known to be associated with a variety of second cancers, including sarcomas. This study describes the prevalence of HL in families affected by sarcoma. METHODS: The International Sarcoma Kindred Study (ISKS) is a prospective cohort of 561 families ascertained via a proband with adult-onset sarcoma. Cancer-specific standardised incidence ratios (SIR) for multiple primary malignancies in probands were estimated. Clinical characteristics of individuals reporting both sarcoma and HL were described. Standardised incidence ratios for the occurrence of cancer in ISKS families were also estimated. RESULTS: Multiple primary cancers were reported in 16% of probands, significantly higher than in the general population. The risk of HL in probands was increased 15.8-fold (95%CI 7.9-31.6) and increased risks were also seen for breast cancer (SIR 2.9, 95%CI 1.9-4.4) and thyroid cancer (SIR 8.4, 95%CI 4.2-16.8). In 8 probands with both HL and sarcoma, the diagnosis of HL preceded that of sarcoma in 7 cases, and occurred synchronously in one case. Only 3 cases of sarcoma occurred in or close to prior radiotherapy fields. The overall incidence of HL in the ISKS cohort was not significantly increased by comparison with age- and gender-specific population estimates (SIR 1.63, 95%CI 1.05-2.43), suggesting that the association between HL and sarcomas did not extend to other family members. The age of onset of non-sarcoma, non-HL cancers in families affected by both HL and sarcoma was younger than the general population (56.2 y vs 65.6 y, P < 0.0001). CONCLUSIONS: The basis for the association between HL and sarcomas may include the carcinogenic effects of therapy combined with excellent survival rates for HL. Common risk factors for both may also exist, including both environmental and heritable factors.
format Online
Article
Text
id pubmed-3351710
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33517102012-05-16 An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma Downing, Megan E Dite, Gillian S Ballinger, Mandy L Clin Sarcoma Res Research BACKGROUND: Sarcomas are rare, often fatal malignancies of connective tissues that can occur in genetic predisposition syndromes or result from carcinogen exposure. Hodgkin's lymphoma (HL) is not known to contribute to any recognised familial cancer syndrome comprising sarcomas, but is known to be associated with a variety of second cancers, including sarcomas. This study describes the prevalence of HL in families affected by sarcoma. METHODS: The International Sarcoma Kindred Study (ISKS) is a prospective cohort of 561 families ascertained via a proband with adult-onset sarcoma. Cancer-specific standardised incidence ratios (SIR) for multiple primary malignancies in probands were estimated. Clinical characteristics of individuals reporting both sarcoma and HL were described. Standardised incidence ratios for the occurrence of cancer in ISKS families were also estimated. RESULTS: Multiple primary cancers were reported in 16% of probands, significantly higher than in the general population. The risk of HL in probands was increased 15.8-fold (95%CI 7.9-31.6) and increased risks were also seen for breast cancer (SIR 2.9, 95%CI 1.9-4.4) and thyroid cancer (SIR 8.4, 95%CI 4.2-16.8). In 8 probands with both HL and sarcoma, the diagnosis of HL preceded that of sarcoma in 7 cases, and occurred synchronously in one case. Only 3 cases of sarcoma occurred in or close to prior radiotherapy fields. The overall incidence of HL in the ISKS cohort was not significantly increased by comparison with age- and gender-specific population estimates (SIR 1.63, 95%CI 1.05-2.43), suggesting that the association between HL and sarcomas did not extend to other family members. The age of onset of non-sarcoma, non-HL cancers in families affected by both HL and sarcoma was younger than the general population (56.2 y vs 65.6 y, P < 0.0001). CONCLUSIONS: The basis for the association between HL and sarcomas may include the carcinogenic effects of therapy combined with excellent survival rates for HL. Common risk factors for both may also exist, including both environmental and heritable factors. BioMed Central 2012-01-09 /pmc/articles/PMC3351710/ /pubmed/22588051 http://dx.doi.org/10.1186/2045-3329-2-1 Text en Copyright ©2012 Downing et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Downing, Megan E
Dite, Gillian S
Ballinger, Mandy L
An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma
title An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma
title_full An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma
title_fullStr An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma
title_full_unstemmed An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma
title_short An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma
title_sort increased incidence of hodgkin's lymphoma in patients with adult-onset sarcoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351710/
https://www.ncbi.nlm.nih.gov/pubmed/22588051
http://dx.doi.org/10.1186/2045-3329-2-1
work_keys_str_mv AT downingmegane anincreasedincidenceofhodgkinslymphomainpatientswithadultonsetsarcoma
AT ditegillians anincreasedincidenceofhodgkinslymphomainpatientswithadultonsetsarcoma
AT ballingermandyl anincreasedincidenceofhodgkinslymphomainpatientswithadultonsetsarcoma
AT downingmegane increasedincidenceofhodgkinslymphomainpatientswithadultonsetsarcoma
AT ditegillians increasedincidenceofhodgkinslymphomainpatientswithadultonsetsarcoma
AT ballingermandyl increasedincidenceofhodgkinslymphomainpatientswithadultonsetsarcoma